The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 22, 2026 | Inrig Jula | CHIEF MEDICAL OFFICER | Gift(G) | 468 | — | $0 |
| Jun 12, 2026 | Coughlin Timothy | Director | Option exercise(M) | 10K | $26.52 | $265K |
| Jun 12, 2026 | Coughlin Timothy | Director | Sell(S) | 10K | $50.07 | $501K |
| Jun 12, 2026 | Coughlin Timothy | Director | Option exercise(M) | 10K | — | $0 |
| Jun 12, 2026 | Baynes Roy D. | Director | Option exercise(M) | 5K | $21.38 | $96K |
| Jun 12, 2026 | Baynes Roy D. | Director | Sell(S) | 5K | $50.00 | $225K |
| Jun 12, 2026 | Baynes Roy D. | Director | Option exercise(M) | 5K | — | $0 |
| May 19, 2026 | Williams Brinkley Ruth | Director | Grant(A) | 12K | — | $0 |
| May 19, 2026 | Williams Brinkley Ruth | Director | Grant(A) | 4K | — | $0 |
| May 19, 2026 | Squarer Ron | Director | Grant(A) | 12K | — | $0 |
| May 19, 2026 | Squarer Ron | Director | Grant(A) | 4K | — | $0 |
| May 19, 2026 | Poole Sandra | Director | Grant(A) | 12K | — | $0 |
| May 19, 2026 | Poole Sandra | Director | Grant(A) | 4K | — | $0 |
| May 19, 2026 | Meckler Jeffrey A | Director | Grant(A) | 12K | — | $0 |
| May 19, 2026 | Meckler Jeffrey A | Director | Grant(A) | 4K | — | $0 |
| May 19, 2026 | Lyons Gary A | Director | Grant(A) | 12K | — | $0 |
| May 19, 2026 | Lyons Gary A | Director | Grant(A) | 4K | — | $0 |
| May 19, 2026 | Orwin John A | Director | Grant(A) | 12K | — | $0 |
| May 19, 2026 | Orwin John A | Director | Grant(A) | 4K | — | $0 |
| May 19, 2026 | Bruhn Suzanne Louise | Director | Grant(A) | 12K | — | $0 |
| May 19, 2026 | Bruhn Suzanne Louise | Director | Grant(A) | 4K | — | $0 |
| May 19, 2026 | Baynes Roy D. | Director | Grant(A) | 12K | — | $0 |
| May 19, 2026 | Baynes Roy D. | Director | Grant(A) | 4K | — | $0 |
| May 19, 2026 | Coughlin Timothy | Director | Grant(A) | 12K | — | $0 |
| May 19, 2026 | Coughlin Timothy | Director | Grant(A) | 4K | — | $0 |
| May 15, 2026 | Coughlin Timothy | Director | Sell(S) | 3K | $43.49 | $141K |
| May 6, 2026 | Rote William E. | Chief Research Officer | Sell(S) | 3K | $43.95 | $121K |
| May 6, 2026 | Reed Elizabeth E | Chief Legal Officer and GC | Sell(S) | 2K | $43.95 | $91K |
| May 6, 2026 | Inrig Jula | CHIEF MEDICAL OFFICER | Sell(S) | 311 | $43.95 | $14K |
| May 6, 2026 | Dube Eric M | CHIEF EXECUTIVE OFFICER, Director | Sell(S) | 23K | $43.95 | $989K |
| May 6, 2026 | Cline Christopher R. | CHIEF FINANCIAL OFFICER | Sell(S) | 310 | $43.95 | $14K |
| May 5, 2026 | Reed Elizabeth E | Chief Legal Officer and GC | Sell(S) | 2K | $46.65 | $101K |
| May 5, 2026 | Heerma Peter | CHIEF COMMERCIAL OFFICER | Sell(S) | 2K | $46.65 | $101K |
| May 5, 2026 | Inrig Jula | CHIEF MEDICAL OFFICER | Sell(S) | 2K | $46.65 | $101K |
| May 5, 2026 | Cline Christopher R. | CHIEF FINANCIAL OFFICER | Sell(S) | 2K | $46.65 | $102K |
| May 5, 2026 | Baynes Roy D. | Director | Option exercise(M) | 5K | — | $0 |
| May 5, 2026 | Baynes Roy D. | Director | Sell(S) | 5K | $46.65 | $210K |
| May 5, 2026 | Baynes Roy D. | Director | Option exercise(M) | 5K | $18.27 | $82K |
| May 4, 2026 | Rote William E. | Chief Research Officer | Option exercise(M) | 4K | — | $0 |
| May 4, 2026 | Rote William E. | Chief Research Officer | Grant(A) | 9K | — | $0 |
| May 4, 2026 | Rote William E. | Chief Research Officer | Option exercise(M) | 4K | — | $0 |
| May 4, 2026 | Reed Elizabeth E | Chief Legal Officer and GC | Option exercise(M) | 4K | — | $0 |
| May 4, 2026 | Reed Elizabeth E | Chief Legal Officer and GC | Grant(A) | 9K | — | $0 |
| May 4, 2026 | Reed Elizabeth E | Chief Legal Officer and GC | Option exercise(M) | 20K | — | $0 |
| May 4, 2026 | Reed Elizabeth E | Chief Legal Officer and GC | Option exercise(M) | 4K | — | $0 |
| May 4, 2026 | Reed Elizabeth E | Chief Legal Officer and GC | Sell(S) | 20K | $45.00 | $900K |
| May 4, 2026 | Reed Elizabeth E | Chief Legal Officer and GC | Option exercise(M) | 20K | $17.96 | $359K |
| May 4, 2026 | Meckler Jeffrey A | Director | Option exercise(M) | 8K | — | $0 |
| May 4, 2026 | Meckler Jeffrey A | Director | Sell(S) | 8K | $45.00 | $360K |
| May 4, 2026 | Meckler Jeffrey A | Director | Option exercise(M) | 8K | $16.33 | $131K |
| May 4, 2026 | Inrig Jula | CHIEF MEDICAL OFFICER | Option exercise(M) | 4K | — | $0 |
| May 4, 2026 | Inrig Jula | CHIEF MEDICAL OFFICER | Grant(A) | 9K | — | $0 |
| May 4, 2026 | Inrig Jula | CHIEF MEDICAL OFFICER | Option exercise(M) | 20K | — | $0 |
| May 4, 2026 | Heerma Peter | CHIEF COMMERCIAL OFFICER | Option exercise(M) | 4K | — | $0 |
| May 4, 2026 | Heerma Peter | CHIEF COMMERCIAL OFFICER | Grant(A) | 9K | — | $0 |
| May 4, 2026 | Heerma Peter | CHIEF COMMERCIAL OFFICER | Option exercise(M) | 4K | — | $0 |
| May 4, 2026 | Inrig Jula | CHIEF MEDICAL OFFICER | Option exercise(M) | 4K | — | $0 |
| May 4, 2026 | Inrig Jula | CHIEF MEDICAL OFFICER | Sell(S) | 20K | $45.00 | $900K |
| May 4, 2026 | Inrig Jula | CHIEF MEDICAL OFFICER | Option exercise(M) | 20K | $22.40 | $448K |
| May 4, 2026 | Dube Eric M | CHIEF EXECUTIVE OFFICER, Director | Option exercise(M) | 23K | — | $0 |
| May 4, 2026 | Dube Eric M | CHIEF EXECUTIVE OFFICER, Director | Grant(A) | 45K | — | $0 |
| May 4, 2026 | Dube Eric M | CHIEF EXECUTIVE OFFICER, Director | Option exercise(M) | 23K | — | $0 |
| May 4, 2026 | Cline Christopher R. | CHIEF FINANCIAL OFFICER | Option exercise(M) | 4K | — | $0 |
| May 4, 2026 | Cline Christopher R. | CHIEF FINANCIAL OFFICER | Grant(A) | 9K | — | $0 |
| May 4, 2026 | Cline Christopher R. | CHIEF FINANCIAL OFFICER | Option exercise(M) | 4K | — | $0 |
| May 1, 2026 | Baynes Roy D. | Director | Option exercise(M) | 10K | $6.82 | $66K |
| May 1, 2026 | Baynes Roy D. | Director | Sell(S) | 10K | $44.22 | $431K |
| May 1, 2026 | Baynes Roy D. | Director | Option exercise(M) | 10K | — | $0 |
| Apr 22, 2026 | Rote William E. | Chief Research Officer | Sell(S) | 9K | $39.09 | $356K |
| Apr 15, 2026 | Inrig Jula | CHIEF MEDICAL OFFICER | Sell(S) | 1K | $42.61 | $43K |
| Apr 15, 2026 | Cline Christopher R. | CHIEF FINANCIAL OFFICER | Sell(S) | 1K | $42.61 | $43K |
| Apr 15, 2026 | Dube Eric M | CHIEF EXECUTIVE OFFICER, Director | Sell(S) | 57K | $41.01 | $2.3M |
| Apr 15, 2026 | Dube Eric M | CHIEF EXECUTIVE OFFICER, Director | Sell(S) | 7K | $41.75 | $299K |
| Apr 15, 2026 | Dube Eric M | CHIEF EXECUTIVE OFFICER, Director | Sell(S) | 20 | $42.66 | $853 |
| Apr 15, 2026 | Reed Elizabeth E | Chief Legal Officer and GC | Sell(S) | 5K | $41.62 | $218K |
| Apr 15, 2026 | Reed Elizabeth E | Chief Legal Officer and GC | Sell(S) | 2K | $42.53 | $66K |
| Apr 14, 2026 | Inrig Jula | CHIEF MEDICAL OFFICER | Sell(S) | 7K | $41.93 | $303K |
| Apr 14, 2026 | Cline Christopher R. | CHIEF FINANCIAL OFFICER | Sell(S) | 9 | $41.07 | $370 |
| Apr 14, 2026 | Cline Christopher R. | CHIEF FINANCIAL OFFICER | Sell(S) | 7K | $41.93 | $304K |
| Apr 14, 2026 | Heerma Peter | CHIEF COMMERCIAL OFFICER | Sell(S) | 7K | $41.93 | $303K |
| Apr 14, 2026 | Reed Elizabeth E | Chief Legal Officer and GC | Option exercise(M) | 10K | $19.08 | $191K |
| Apr 14, 2026 | Reed Elizabeth E | Chief Legal Officer and GC | Option exercise(M) | 20K | $17.96 | $359K |
| Apr 14, 2026 | Reed Elizabeth E | Chief Legal Officer and GC | Option exercise(M) | 8K | $15.46 | $116K |
| Apr 14, 2026 | Reed Elizabeth E | Chief Legal Officer and GC | Sell(S) | 38K | $41.07 | $1.5M |
| Apr 14, 2026 | Reed Elizabeth E | Chief Legal Officer and GC | Sell(S) | 7K | $41.93 | $303K |
| Apr 14, 2026 | Reed Elizabeth E | Chief Legal Officer and GC | Option exercise(M) | 8K | — | $0 |
| Apr 14, 2026 | Reed Elizabeth E | Chief Legal Officer and GC | Option exercise(M) | 10K | — | $0 |
| Apr 14, 2026 | Reed Elizabeth E | Chief Legal Officer and GC | Option exercise(M) | 20K | — | $0 |
| Apr 14, 2026 | Baynes Roy D. | Director | Option exercise(M) | 8K | $17.94 | $144K |
| Apr 14, 2026 | Baynes Roy D. | Director | Option exercise(M) | 9K | $15.43 | $139K |
| Apr 14, 2026 | Baynes Roy D. | Director | Option exercise(M) | 5K | $18.27 | $82K |
| Apr 14, 2026 | Baynes Roy D. | Director | Option exercise(M) | 5K | $21.38 | $96K |
| Apr 14, 2026 | Baynes Roy D. | Director | Option exercise(M) | 7K | $17.11 | $115K |
| Apr 14, 2026 | Baynes Roy D. | Director | Sell(S) | 26K | $41.07 | $1.1M |
| Apr 14, 2026 | Baynes Roy D. | Director | Sell(S) | 7K | $42.12 | $284K |
| Apr 14, 2026 | Baynes Roy D. | Director | Option exercise(M) | 8K | — | $0 |
| Apr 14, 2026 | Baynes Roy D. | Director | Option exercise(M) | 9K | — | $0 |
| Apr 14, 2026 | Baynes Roy D. | Director | Option exercise(M) | 5K | — | $0 |
| Apr 14, 2026 | Baynes Roy D. | Director | Option exercise(M) | 5K | — | $0 |
| Apr 14, 2026 | Baynes Roy D. | Director | Option exercise(M) | 7K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-11. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).